Literature DB >> 9300706

Heterogeneity of biologic responses of melanoma-specific CTL.

J F Fonteneau1, E Le Dréan, S Le Guiner, N Gervois, E Diez, F Jotereau.   

Abstract

To better understand how Ag density influences the various biologic responses of CTL, we analyzed lysis and, at the single cell level, cytokine production by a panel of melanoma-specific CTL clones. Titration experiments done with peptide-pulsed TAP-deficient T2 cells indicated that: 1) Ag density affects both the fraction of responding cells and the amount of cytokine secreted by each cell. 2) Different responses have a relative Ag requirement that may vary between clones. Lysis and secretion of IFN-gamma, and for most clones' secretion of TNF-alpha, required lower Ag densities, by one or two logs, than IL-2 and granulocyte-macrophage CSF secretion. 3) In a significant fraction of IFN-gamma-secreting cells, IL-2 production is not induced. 4) A large fraction of cloned cells is refractory to lymphokine gene activation for about 2 wk after previous stimulation. Together these data indicate that CTL biologic responses are controlled by variable Ag thresholds and by additional parameters affecting activation requirements of each cell. A similar heterogeneity of cytokine responses was observed to Ag endogenously presented by melanoma cells. As a consequence, most melanoma lines, including those with the highest Ag expression, could trigger only low CTL fractions to secrete IL-2 and, also for most clones, granulocyte-macrophage CSF. This may be an important component of the inefficiency of specific CTL in cancer patients.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9300706

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  3 in total

1.  High frequency of circulating HBcAg-specific CD8 T cells in hepatitis B infection: a flow cytometric analysis.

Authors:  S Matsumura; K Yamamoto; N Shimada; N Okano; R Okamoto; T Suzuki; T Hakoda; M Mizuno; T Higashi; T Tsuji
Journal:  Clin Exp Immunol       Date:  2001-06       Impact factor: 4.330

2.  CD4CD8αα lymphocytes, a novel human regulatory T cell subset induced by colonic bacteria and deficient in patients with inflammatory bowel disease.

Authors:  Guillaume Sarrabayrouse; Céline Bossard; Joe-Marc Chauvin; Anne Jarry; Guillaume Meurette; Elodie Quévrain; Chantal Bridonneau; Laurence Preisser; Karim Asehnoune; Nathalie Labarrière; Frédéric Altare; Harry Sokol; Francine Jotereau
Journal:  PLoS Biol       Date:  2014-04-08       Impact factor: 8.029

Review 3.  Identifying Individual T Cell Receptors of Optimal Avidity for Tumor Antigens.

Authors:  Michael Hebeisen; Mathilde Allard; Philippe O Gannon; Julien Schmidt; Daniel E Speiser; Nathalie Rufer
Journal:  Front Immunol       Date:  2015-11-18       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.